Dosing mechanism for a drug deliver device

US9463283B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9463283-B2
Application numberUS-78871810-A
CountryUS
Kind codeB2
Filing dateMay 27, 2010
Priority dateJun 1, 2009
Publication dateOct 11, 2016
Grant dateOct 11, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A maximum settable dose feature is disclosed that is set by a user or health care professional one time that prevents future injections from exceeding the desired maximum dose. The feature includes a locking band initially in an unlocked configuration, which transforms to a locked configuration when activated after setting a desired maximum dose. The feature can include a trigger mechanism to transform the locking band to the locked configuration.

First claim

Opening claim text (preview).

The invention claimed is: 1. A maximum settable dose feature for a drug delivery device comprising, in combination, a) a movable dose setting component configured to move in a first direction and a reverse direction opposite the first direction to set a first dose; b) a locking band having an unlocked configuration in rotational or linear engagement with the dose setting component and a locked configuration that provides a permanent stop for the dose setting component; c) a collar engaged with the dose setting component such that the collar moves proximal with the dose setting component; wherein the locking band in the unlocked configuration is engaged with the collar such that it moves in a proximal direction during the setting of the first dose and is configured to transition from the unlocked to the locked configuration after a first dose is set and when the collar is disengaged from the locking member and moved in a distal direction, and wherein the locking band is further configured to transition from the unlocked configuration to the locked configuration when disengaged from the dose setting component as a result of the dose setting component being rotated or linearly moved in the reverse direction. 2. The maximum settable dose feature of claim 1 where the locking band has a greater diameter in the unlocked configuration than when in the locked configuration. 3. The locking mechanism of claim 1 where the locking band has a leading edge and a trailing edge and engages with a spring finger, wherein the spring finger holds one or both edges of the locking band in the unlocked configuration prior to setting of the first dose. 4. The locking mechanism of claim 1 further comprising a release trigger that maintains the locking band in the first unlocked configuration and wherein the locking band transitions from the first to the second position after a first dose is set when a user activates the trigger. 5. An irreversible locking mechanism for setting a maximum dose for a drug delivery device comprising, in combination, a) a stationary inner body having a distal end, a proximal end and a helical grove positioned along its axis from the proximal end to the distal end; b) a rotatable number sleeve; c) a threaded collar attached to the number sleeve that rotates and moves proximally with number sleeve about the helical grove of the inner body during setting of a first dose; d) a locking band having a first unlocked configuration on the inner body and being engaged with the collar such that it moves in a proximal direction during the setting of the first dose and having a second locked configuration on the inner body; wherein the locking band transitions from the first to the second configuration after a first dose is set as a result of the threaded collar being rotated in a reverse direction causing the collar to disengage from the locking band and to move in a distal direction, and wherein the locking band in the second locked configuration is rotationally fixed to the inner body through frictional engagement. 6. The locking mechanism of claim 5 where the locking band has a leading edge and a trailing edge and engages with a spring finger, wherein the spring finger holds one or both edges of the locking band in the unlocked configuration prior to setting of the first dose. 7. The locking mechanism of claim 6 where the spring finger biases the leading edge away from the inner body when the locking band is in the first unlocked configuration. 8. The locking mechanism of claim 6 where the trailing edge of the locking band grips the inner body when the locking band is in the second locked configuration. 9. The locking mechanism of claim 5 where the locking band is rotatably engaged by the threaded collar when the locking band is in the unlocked configuration and is free to rotate about the inner body. 10. The locking mechanism of claim 5 where the locking band is disengaged from the threaded collar after a first dose is set and is irreversibly locked to the inner body. 11. The locking mechanism of claim 5 wherein the locking band in the locked configuration is a dose stop defining a maximum settable dose that engages the threaded collar during setting of a second dose. 12. A method of setting a permanent maximum settable dose in a drug delivery device having, a) a movable dose setting component; b) a locking band having an unlocked configuration in rotational or linear engagement with the dose setting component and a locked configuration that provides a permanent stop for the dose setting component; wherein the locking band transitions from the unlocked to the locked configuration after a first dose is set; and c) a collar engaged with the dose setting component and the locking band such that collar and locking band move with the dose setting component during setting of the first dose; the method comprises, c) rotating or pulling the dose setting component to set a first dose; d) rotating or pulling the locking band in the unlocked position while in rotational or linear engagement with the dose setting component; e) stopping rotation or linear movement of the dose setting component when the first dose is reached; and f) reversing rotation or linear movement of the dose setting component causing the collar to disengage from the locking band to allow the locking band to transition from the unlocked to the locked configuration. 13. A method of setting a permanent maximum settable dose in a drug delivery device having, a) an inner body with a distal end, a proximal end, and a helical grove positioned along its axis from the proximal end to the distal end; b) a rotatable number sleeve; c) a threaded collar attached to the number sleeve that rotates with number sleeve about the helical grove of the inner body; d) a locking band having a first unlocked configuration on the inner body and a second locked configuration on the inner body; the method comprises, e) rotating the number sleeve to set a first dose; f) rotating the threaded collar with the number sleeve during setting of the first dose, where the threaded collar and number sleeve move in the proximal direction with the threaded collar engaging the helical grove of the inner body; g) rotating the locking band in the unlocked position while in rotational engagement with the threaded collar; h) stopping rotation of the number sleeve when the first dose is reached; and i) reversing rotation of the number sleeve causing the threaded collar to move distally along the helical grove of the inner body and to disengage from the locking band causing the locking band to irreversible engage the inner body. 14. The method of claim 13 where the locking band has a leading edge and a trailing edge and engages with a spring finger, and rotating the threaded sleeve in a distal direction causes the spring finger to release a biasing force on the leading edge and contracting the locking band to irreversibly engage the inner body. 15. An irreversible locking mechanism for setting a maximum dose for a drug delivery device comprising, in combination, a) a stationary inner body having a distal end, a proximal end, and a helical grove positioned along its axis from the proximal end to the distal end; b) a rotatable number sleeve; c) a threaded collar attached to the number sleeve that rotates with a number sleeve while engaged with the helical grove of the inner body, where the threaded collar is in rotational engagement with the number sleeve during setting of a first dose such that the threaded collar and number sleeve move in the proximal direction as th

Assignees

Inventors

Classifications

  • by purely axial movement of dose setting member, e.g. during setting or filling of a syringe · CPC title

  • Permanent blocking, e.g. by medical personnel · CPC title

  • Means preventing setting of a dose beyond the amount remaining in the cartridge · CPC title

  • Pre-defined multi-dose administration by repeated overcoming of means blocking the free advancing movement of piston rod, e.g. by tearing or de-blocking · CPC title

  • Setting modes for dosing · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9463283B2 cover?
A maximum settable dose feature is disclosed that is set by a user or health care professional one time that prevents future injections from exceeding the desired maximum dose. The feature includes a locking band initially in an unlocked configuration, which transforms to a locked configuration when activated after setting a desired maximum dose. The feature can include a trigger mechanism to t…
Who is the assignee on this patent?
Jones Christopher John, Sanofi Aventis Deutschland
What technology area does this patent fall under?
Primary CPC classification A61M5/31538. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).